Overview

Metformin for Pulmonary Hypertension HFpEF

Status:
Active, not recruiting

Trial end date:
2023-09-01

Target enrollment:

Participant gender:

Summary

The main objective of this study is to determine the clinical efficacy of metformin versus placebo and the therapeutic response with regards to functional capacity and hemodynamics in PH-HFpEF.

Phase:

Phase 2

Details

Lead Sponsor:

Marc A. Simon
University of California, San Francisco

Collaborator:

National Institute on Aging (NIA)

Treatments:

Metformin